CMS to analyze coverage of monoclonal antibody Alzheimer's drug

The U.S. Centers for Medicare and Medicaid Services (CMS) will conduct a nationa...Read more on AuntMinnie.comRelated Reading: fMRI shows dementia patients' brain response to music New Alzheimer's definition relies on imaging biomarkers DTI-MRI ties lack of fitness to cognitive decline Flortaucipir-PET could lead in early Alzheimer's detection ACR revises Appropriateness Criteria
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news